Payden & Rygel将其McKessson股份削减22.5%, 尽管该公司最近创下12个月的高点。 Payden & Rygel cut its McKesson shares by 22.5%, despite the company hitting a 12-month high recently.

投资公司Payden & Rygel将其在McKessson公司(NYSE:MCK)的股份减少了22.5%,出售了8 900股,剩下30 700股,价值1 750万美元。 Investment firm Payden & Rygel reduced its holdings in McKesson Corporation (NYSE:MCK) by 22.5%, selling 8,900 shares, leaving it with 30,700 shares valued at $17.5 million. 医疗保健服务提供商 McKesson 最近在瑞穗将目标价上调至 690 美元后创下 12 个月新高。 McKesson, a healthcare services provider, recently hit a new 12-month high after Mizuho raised its price target to $690. 尽管如此,McKesson在其上一份季度报告中错过了分析员的收入估计数,报告EPS为8.03美元,而预期为8.60美元。 Despite this, McKesson missed analysts' earnings estimates in its last quarterly report, reporting EPS of $8.03 compared to the expected $8.60.